We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Francisco Kerdel

Francisco A. Kerdel BSc, MBBS

Florida Academic Dermatology Centers, Coral Gables, Florida

Francisco A. Kerdel, M.D. attended the St. Thomas Hospital Medical School, London University, London, United Kingdom. He completed his dermatology residency at Harvard Medical School, Boston, MA. where he was chief resident during the year 1983-1984. He completed Fellowships at Guy's Hospital, London, England and New York University School of Medicine, New York, NY. He is the former Director of Dermatology Inpatient Unit at the University of Miami hospital, Miami, FL., and former Professor of Dermatology at the University of Miami. Dr. Kerdel is past President of the International Society of Dermatology. He is currently a clinical professor at Florida International University where he is also the Vice Chairman of the Dept of Dermatology. Society memberships include the American Academy of Dermatology, American Dermatological Association and Noah Worcester Dermatological Society. Dr. Kerdel has been chosen an Honorary Member of the Venezuelan, Argentinean and Chilean Societies of Dermatology and a corresponding member of the Venezuelan Academy of Medicine. Over 250 scientific articles, 37 books and book chapters have been authored by Dr. Kerdel. As an invited speaker, Dr. Kerdel has spoken at national meetings and at international meetings worldwide. He has been a visiting professor in the United States, Japan, Portugal, Italy, Australia, Argentina, Brazil, Chile, Spain, Paraguay, United Kingdom, Venezuela, Colombia, Uruguay and Mexico.

Disclosures

Dr. Kerdel reports the following:
Company Speaker Research Board
Lilly x x  
Amgen x    
X-Biotech   x  
Janssen x x  
Abbvie x x  
Pfizer x x  
Celgene x x x
Novartis x x  
AstroZeneca   x  
Dr. Reddys   x  
Ortho x x  
UCB x x  
Leo x x  
Menlo   x  
Sanofi x    
Regeneron x x  
Sun   x  
Brickell   x  

Recent Contributions to PracticeUpdate:

  1. Effect of Older Age on Complications and Mortality in SJS/TEN